Sepsis-Induced Endothelial Dysfunction: Permeability and Regulated Cell Death
Wei Zhang,Luofeng Jiang,Xirui Tong,Heng He,Yongjun Zheng,Zhaofan Xia
DOI: https://doi.org/10.2147/jir.s479926
IF: 4.5
2024-11-28
Journal of Inflammation Research
Abstract:Wei Zhang, 1, &ast Luofeng Jiang, 1, &ast Xirui Tong, 1, &ast Heng He, 1, &ast Yongjun Zheng, 1 Zhaofan Xia 1, 2 1 Department of Burn Surgery, the First Affiliated Hospital of Naval Medical University, Shanghai, 200433, People's Republic of China; 2 Research Unit of Key Techniques for Treatment of burns and Combined Burns and Trauma Injury, Chinese Academy of Medical Sciences, Shanghai, 200433, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhaofan Xia; Yongjun Zheng, Department of Burn Surgery, the First Affiliated Hospital of Naval Medical University, Shanghai, 200433, People's Republic of China, Email ; Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Endothelial cells (ECs) are an important cell type typically affected in sepsis, resulting in compromised barrier function and various forms of regulated cell death (RCD). However, the precise mechanisms underlying sepsis-induced EC damage remain unclear. This review summarizes the recent research progress on factors and mechanisms that may affect the permeability and RCD of ECs under septic conditions, including glycocalyx, damage-associated molecular patterns, and various forms of RCD in ECs, such as apoptosis, pyroptosis, ferroptosis, and autophagy. This review offers important insights into the underlying mechanisms of endothelial dysfunction in sepsis, aiming to contribute to developing small-molecule targeted clinical therapies. Keywords: damage-associated protein, endothelial cell, glycocalyx, permeability, regulated cell death, sepsis Graphical As outlined in the most recent international consensus, sepsis is a severe organ dysfunction that continues to pose a significant threat to public health. 1 In 2017, an estimated 48.9 million cases and 11 million sepsis-related fatalities worldwide were documented, constituting roughly 20% of the annual global mortality. 2 The damage and dysfunction of vascular endothelial cells (ECs) are the shared characteristics in systemic reactions caused by sepsis. Under physiological conditions, the extensive microvessels in the alveoli facilitate effective gas exchange. Meanwhile, ECs establish a semi-permeable membrane barrier that regulates the passage of fluids, proteins, and cells into tissues, thus maintaining the microvascular bed in an anti-thrombotic and anti-inflammatory state. 3 However, during infections, including bacterial, fungal, or viral infections, both exogenous pathogen-associated molecular patterns (PAMPs) and endogenous damage-associated molecular patterns (DAMPs) can induce overactivation of ECs, impair vascular integrity and barrier function, leading to increased permeability, interstitial edema, and other serious disruptions to gas exchange. 3 Impaired EC function in vital organs can be particularly fatal. The lungs are the most susceptible target organ in cases of sepsis. This can result in the development of acute lung injury (ALI) and even acute respiratory distress syndrome (ARDS) finally. 4 Similarly, EC damage and dysfunction can lead to damage to other vital organs, such as acute liver injury, 5 acute kidney injury (AKI), 6 encephalopathy, 7 and disseminated intravascular coagulation (DIC). 8 Thus, it is particularly important to analyze the specific mechanisms by which EC dysfunction occurs under septic conditions. This review summarizes the recent research progress on factors and mechanisms that may affect the permeability and regulated cell death (RCD) of ECs under septic conditions, including glycocalyx, DMAPs, and various forms of RCD in ECs, such as apoptosis, pyroptosis, ferroptosis, and autophagy. This review offers important insights into the underlying mechanisms of endothelial dysfunction in sepsis, aiming to contribute to developing small-molecule targeted clinical therapies. The GCX is a large molecular substance that attaches to the luminal surface of ECs. Initially identified in 1966 via ruthenium red staining by Luft and his team, 9 the GCX comprises sulfated proteoglycans (including syndecans and glypicans), glycosaminoglycans (such as hyaluronic acid [HA], heparan sulfate [HS], and chondroitin sulfate), and sialic acid proteins. 10,11 In addition to the well-researched cell–cell junction, the GCX plays a crucial role in maintaining barrier function. 12 It can respond to shear stress sensed in the bloodstream by modulating vasoconstriction via the regulation of nitric oxide (NO), a biologically important inorganic compound that facilitates vasodilation and controls vascular -Abstract Truncated-
immunology